Montelukast Sodium Powder

Product Name: Montelukast Sodium Raw Materials

Brand: Henrikang

Appearance: White Powder

Storage: Cool Dry Place

Shelf Life: 2 Years

Specification​: 99% min Montelukast Sodium

Test Method: HPLC

CAS: 151767-02-1

MF: C35H35ClNNaO3S

Sample: Montelukast Sodium Powder

Keywords: Montelukast Sodium,Montelukast Sodium Supplier,Montelukast Sodium API,China Montelukast Sodium manufacturers

Montelukast Sodium Product Introduction:
Montelukast sodium is a non-hormonal anti-inflammatory drug and is a leukotriene receptor antagonist with good tolerance. It is mostly used in clinical practice for patients aged 15 and above with bronchial asthma, allergic rhinitis, and Inflammation, cough variant asthma and other patients. A large amount of clinical evidence shows that patients taking montelukast sodium generally experience adverse reactions such as abdominal pain, dry mouth, pharyngitis, upper respiratory tract infection, irritability, hallucinations, edema, fever, and excessive excitement. When taking sodium, you must follow the doctor's advice and take it under the guidance of a doctor. Do not use it without authorization to avoid danger. Patients who are allergic to montelukast sodium should not use it.

Montelukast sodium is one of the routine medications in respiratory department, which belongs to leukotriene receptor antagonist. It is generally used as a combined drug for patients with bronchial asthma that is common in the Department of Respiratory Medicine. Patients with allergic rhinitis are generally used in combination with glucocorticoids, and the two can have a synergistic effect, which can significantly increase the efficacy of the drug. However, when used in combination, the dosage should be used reasonably under the guidance of a doctor. Generally, the course of treatment for montelukast sodium is clinically recommended for 4-8 weeks, and the drug cannot be stopped without authorization. Be sure to standardize the medication under the guidance of the doctor and stop the medication reasonably. Montelukast sodium is relatively safe, and it can be used by children in general, but it should be used with caution for pregnant women, and it can only be used when there are indications.

Asthma control indicators are used to evaluate the therapeutic effect, and the curative effect of the drug will appear within one day of medication.
Medicines can be taken with food or separately. Patients should be advised to adhere to their medications both during asthma control and exacerbation phases. Generally, three months is a course of treatment, and then asthma assessment is performed to upgrade or downgrade treatment.
Elderly patients, patients with renal insufficiency, patients with mild to moderate hepatic impairment and patients of different genders do not need to adjust the dose.
Relationship with other therapeutic drugs:
Medicines can be added to a patient's existing treatment regimen.
Reduce the dose of concomitant medications:
bronchodilator
For patients with asthma who cannot be effectively controlled by bronchodilators alone, this product can be added to the treatment plan. Once there is an obvious clinical response (usually after the first dose). The dose of bronchodilator can be reduced according to the patient's tolerance.